Clinical Trials Directory

Trials / Completed

CompletedNCT02714231

Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

A Randomized Controlled Trial of 2 Different Methods for Pain Relief During Intrauterine Device Insertion

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus oral hyoscine butyl bromide during intrauterine device insertion.

Conditions

Interventions

TypeNameDescription
DRUGdiclofenac sodium (cataflam)The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure
DRUGhyoscine butyl bromide (buscopan)The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure

Timeline

Start date
2016-03-01
Primary completion
2017-02-01
Completion
2017-03-01
First posted
2016-03-21
Last updated
2017-07-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02714231. Inclusion in this directory is not an endorsement.